• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol. Patient Follow-up after Discharge after COVID-19 Pneumonia: Considerations for Infectious Control

tetano

Editor, Senior Moderator
J Med Virol. 2020 May 8. doi: 10.1002/jmv.25994. [Epub ahead of print]
Patient Follow-up after Discharge after COVID-19 Pneumonia: Considerations for Infectious Control.


Zheng Z[SUP]1,[/SUP][SUP]2[/SUP], Yao Z[SUP]1,[/SUP][SUP]2[/SUP], Wu K[SUP]1,[/SUP][SUP]2[/SUP], Zheng J[SUP]1,[/SUP][SUP]2[/SUP].

Author information




Abstract

Coronavirus disease 2019 (COVID-19) represents a significant global medical issue, with a growing number of cumulative confirmed cases. However, a large number of COVID-19 patients have overcome the disease, meeting hospital discharge criteria, and are gradually returning to work and social life. Nonetheless, COVID-19 may cause further downstream issues in these patients, such as due to possible reactivation of the virus, long-term pulmonary defects, and post-traumatic stress disorder. In this study, we therefore queried relevant literature concerning SARS, MERS, and COVID-19 for reference to come to a consensus on follow-up strategies. We found that strategies such as implementation of PCR testing, imaging surveillance, and psychological assessments, starting at the time of discharge, were necessary for long-term follow-up. If close care is given to every aspect of coronavirus management, we expect that the pandemic outbreak will soon be overcome. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.



KEYWORDS:

Middle East Respiratory Syndrome; Severe Acute Respiratory Syndrome; coronavirus disease 2019; discharge; follow-up


PMID:32383776DOI:10.1002/jmv.25994
 
Back
Top Bottom